Back to Agenda
SESSION 7: ePI: Where are we?
Session Chair(s)
Imane Hattami
Therapeutic Area Head and Regulatory Policy Intelligence MEAR, Abbvie Biopharmaceuticals Gmbh, Morocco
Ronnie Mundair
Regional Labelling Head - Canada and LATAM - Senior Director, Pfizer, United Kingdom
Overview: In this session, we will hear from Industry Regulatory Experts and Regulators from the MENA region on regional insights, success stories and challenges, and how the adoption of the ePI can support the overall medicines ecosystem.
Speaker(s)
Ronnie Mundair
Regional Labelling Head - Canada and LATAM - Senior Director, Pfizer, United Kingdom
Stefano Accorsi, MBA, MSC
Senior Director, Global Regulatory Affairs Policy, Intelligence and Affiliates, Chiesi Farmaceutici S.p.A., Italy
Bernhard Salb
Global Supply Chain Project Manager, Roche, Switzerland
Ronnie Mundair
Regional Labelling Head - Canada and LATAM - Senior Director, Pfizer, United Kingdom
Mohammed Abdelaal
Supervisor - Drug Registration & Pricing Section, Pharmacy & Drug Depart., Ministry of Public Health (MOPH), Qatar, Qatar
Mohammad Rabi, PHARMD
IT Specialist · Drug Directorate, Jordan Food and Drug Administration (JFDA), Jordan
Rehab Mehriz
Manager - General Administration of Pharmaceutical References & leaflets, Egyptian Drug Authority (EDA), Egypt
Lynsey Flitton
Director, Strategic Global Labeling, Europe, AbbVie, United Kingdom
Have an account?